These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11910273)

  • 1. Donepezil management of schizophrenia with associated dementia.
    Stryjer R; Bar F; Strous RD; Baruch Y; Rabey JM
    J Clin Psychopharmacol; 2002 Apr; 22(2):226-9. PubMed ID: 11910273
    [No Abstract]   [Full Text] [Related]  

  • 2. Combination of risperidone and donepezil in Lewy body dementia.
    Geizer M; Ancill RJ
    Can J Psychiatry; 1998 May; 43(4):421-2. PubMed ID: 9598283
    [No Abstract]   [Full Text] [Related]  

  • 3. Double-blind donepezil-placebo crossover augmentation study of atypical antipsychotics in chronic, stable schizophrenia: a pilot study.
    Risch SC; Horner MD; McGurk SR; Palecko S; Markowitz JS; Nahas Z; DeVane CL
    Schizophr Res; 2007 Jul; 93(1-3):131-5. PubMed ID: 17391930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extrapyramidal side-effect due to drug combination of risperidone and donepezil.
    Liu HC; Lin SK; Sung SM
    Psychiatry Clin Neurosci; 2002 Aug; 56(4):479. PubMed ID: 12109969
    [No Abstract]   [Full Text] [Related]  

  • 5. Donepezil for memory dysfunction in schizophrenia.
    Howard AK; Thornton AE; Altman S; Honer WG
    J Psychopharmacol; 2002 Sep; 16(3):267-70. PubMed ID: 12236636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two cases of quetiapine augmentation for donepezil-refractory visual hallucinations in dementia with Lewy bodies.
    Terao T; Shimomura T; Izumi Y; Nakamura J
    J Clin Psychiatry; 2003 Dec; 64(12):1520-1. PubMed ID: 14728121
    [No Abstract]   [Full Text] [Related]  

  • 7. [Efficacy of adjunctive donepezil for cognitive impairments in patients with schizophrenia].
    Mazza M; Pollice R; Gaspari V; Giosue P; Fragkou E; Roncone R; Casacchia M
    Clin Ter; 2005; 156(5):203-9. PubMed ID: 16382969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent administration of donepezil HCl and risperidone in patients with schizophrenia: assessment of pharmacokinetic changes and safety following multiple oral doses.
    Reyes JF; Preskorn SH; Khan A; Kumar D; Cullen EI; Perdomo CA; Pratt RD
    Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):50-7. PubMed ID: 15496223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beneficial effect of donepezil augmentation for the management of comorbid schizophrenia and dementia.
    Stryjer R; Strous RD; Bar F; Werber E; Shaked G; Buhiri Y; Kotler M; Weizman A; Rabey JM
    Clin Neuropharmacol; 2003; 26(1):12-7. PubMed ID: 12567159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double blind placebo controlled trial of donepezil adjunctive treatment to risperidone for the cognitive impairment of schizophrenia.
    Friedman JI; Adler DN; Howanitz E; Harvey PD; Brenner G; Temporini H; White L; Parrella M; Davis KL
    Biol Psychiatry; 2002 Mar; 51(5):349-57. PubMed ID: 11904128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges in the management of delirium: a case of augmentation with donepezil following inadequate response and adverse effects with risperidone.
    Stocker L; Jellestad L; Jenewein J; Boettger S
    Psychiatr Danub; 2015 Mar; 27(1):64-6. PubMed ID: 25751433
    [No Abstract]   [Full Text] [Related]  

  • 12. Donepezil for negative signs in elderly patients with schizophrenia: an add-on, double-blind, crossover, placebo-controlled study.
    Mazeh D; Zemishlani H; Barak Y; Mirecki I; Paleacu D
    Int Psychogeriatr; 2006 Sep; 18(3):429-36. PubMed ID: 16478570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroleptic malignant syndrome and catatonia in a patient with dementia.
    Singh D; Forlano R; Athey R
    Aust N Z J Psychiatry; 2008 Jun; 42(6):547-8. PubMed ID: 18494081
    [No Abstract]   [Full Text] [Related]  

  • 14. A 12-week, double-blind, placebo-controlled trial of donepezil adjunctive treatment to risperidone in chronic and stable schizophrenia.
    Akhondzadeh S; Gerami M; Noroozian M; Karamghadiri N; Ghoreishi A; Abbasi SH; Rezazadeh SA
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1810-5. PubMed ID: 18727948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down syndrome and Alzheimer disease: response to donepezil.
    Lott IT; Osann K; Doran E; Nelson L
    Arch Neurol; 2002 Jul; 59(7):1133-6. PubMed ID: 12117361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Safety of Sustained Release Donepezil High Dose versus Immediate Release Donepezil Standard Dose in Japanese Patients with Severe Alzheimer's Disease: A Randomized, Double-Blind Trial.
    Homma A; Atarashi H; Kubota N; Nakai K; Takase T
    J Alzheimers Dis; 2016 Mar; 52(1):345-57. PubMed ID: 26967222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dementia: finding the signals in the noise.
    Jagust W
    Lancet Neurol; 2005 Jan; 4(1):10-1. PubMed ID: 15620851
    [No Abstract]   [Full Text] [Related]  

  • 18. Dementia with Lewy bodies: response of delirium-like features to donepezil.
    Kaufer DI; Catt KE; Lopez OL; DeKosky ST
    Neurology; 1998 Nov; 51(5):1512. PubMed ID: 9818904
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of donepezil dose escalation in Parkinson's patients with dementia receiving long-term donepezil treatment: an exploratory study.
    Ishikawa K; Motoi Y; Mizuno Y; Kubo S; Hattori N
    Psychogeriatrics; 2014 Jun; 14(2):93-100. PubMed ID: 24661498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What happens when donepezil is suddenly withdrawn? An open label trial in dementia with Lewy bodies and Parkinson's disease with dementia.
    Minett TS; Thomas A; Wilkinson LM; Daniel SL; Sanders J; Richardson J; Littlewood E; Myint P; Newby J; McKeith IG
    Int J Geriatr Psychiatry; 2003 Nov; 18(11):988-93. PubMed ID: 14618549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.